Residency · Residency · Physical Medicine Rehabilitation
Sleep Disorders in Rehabilitation Populations
Introduction
Sleep disturbances are pervasive in rehabilitation populations yet remain under-recognized and undertreated. Poor sleep impairs neuroplasticity, cognitive recovery, pain modulation, immune function, and participation in therapy. Patients with traumatic brain injury, spinal cord injury, stroke, chronic pain, and neurodegenerative conditions are at particularly high risk for clinically significant sleep disorders. Physiatrists must screen for sleep disturbances, identify treatable causes, and implement evidence-based interventions as part of comprehensive rehabilitation care.
Normal Sleep Physiology
Sleep is regulated by two primary processes: the circadian rhythm (Process C) driven by the suprachiasmatic nucleus (SCN) of the hypothalamus, and sleep homeostasis (Process S) driven by accumulation of adenosine during wakefulness. Sleep architecture: cycles of non-rapid eye movement (NREM) and rapid eye movement (REM) sleep, each cycle lasting approximately 90 minutes. N1: light sleep, transition stage (5% of total sleep). N2: sleep spindles and K-complexes; memory consolidation (45-55%).
N3 (slow-wave sleep): deepest stage; growth hormone secretion, tissue repair, immune function (15-20%). REM sleep: dreaming, emotional processing, memory consolidation (20-25%). Melatonin: secreted by the pineal gland in response to darkness; entrained by the light-dark cycle; peak secretion at 2-4 AM. Normal adult sleep need: 7-9 hours; declines modestly with aging.
Sleep Disorders Common in Rehabilitation
Obstructive Sleep Apnea (OSA)
Prevalence: 50-70% in stroke survivors, 40-60% in SCI, 25-50% in TBI. Recurrent upper airway collapse during sleep causing apneas and hypopneas. Risk factors: obesity, male sex, neck circumference greater than 17 inches, retrognathia, nasal obstruction. In SCI, tetraplegia carries higher risk due to supine positioning, abdominal obesity pattern, and loss of upper airway muscle tone.
Consequences: excessive daytime sleepiness, cognitive impairment, hypertension, increased stroke recurrence risk, impaired rehabilitation participation.
Insomnia
Most common sleep complaint in rehabilitation; affects 30-70% of patients across diagnoses. Characterized by difficulty initiating sleep, maintaining sleep, or early morning awakening with daytime impairment. Contributing factors: pain, anxiety, depression, environmental disruption (noise, light, nursing interventions), medications, altered circadian rhythms. Chronic insomnia (3 months or more) often develops from acute insomnia through maladaptive cognitive and behavioral patterns.
Circadian Rhythm Disorders
Common after TBI due to damage to SCN pathways and disrupted melatonin production. Irregular sleep-wake rhythm disorder: fragmented sleep without a clear circadian pattern; seen in moderate-severe TBI and dementia. Delayed sleep-wake phase disorder: sleep onset and wake time shifted later; common in adolescents and young adults with TBI. Institutional rehabilitation environments may lack sufficient light cues to entrain circadian rhythms.
Central Sleep Apnea
Cessation of respiratory effort during sleep due to loss of brainstem drive. Associated with cervical SCI (particularly high cervical injuries), brainstem stroke, heart failure, and opioid use. Opioid-induced central apnea: dose-dependent; occurs with morphine equivalent doses of 200 mg or more daily but can occur at lower doses.
Restless Legs Syndrome and Periodic Limb Movement Disorder
RLS prevalence: elevated in SCI (15-25%), multiple sclerosis, and chronic kidney disease. Characterized by an irresistible urge to move legs, worse at rest and in the evening, relieved by movement. Associated with iron deficiency (ferritin less than 50 ng/mL), dopaminergic dysfunction, and certain medications (SSRIs, antihistamines). Periodic limb movement disorder (PLMD): repetitive limb movements during sleep causing arousals; often coexists with RLS.
Assessment
Screening tools: STOP-BANG Questionnaire (OSA risk), Epworth Sleepiness Scale (ESS; excessive daytime sleepiness), Insomnia Severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI). Sleep diary: 2-week prospective record of sleep-wake times, naps, awakenings, and subjective quality. Polysomnography (PSG): gold standard for diagnosing OSA, central apnea, PLMD, and parasomnias; attended in-laboratory study. Home sleep apnea testing (HSAT): portable device for uncomplicated suspected OSA; not appropriate for central apnea, neuromuscular disease, or comorbid conditions.
Actigraphy: wrist-worn accelerometer measuring rest-activity cycles over days to weeks; useful for circadian rhythm disorders and insomnia assessment. Multiple Sleep Latency Test (MSLT): objective measure of daytime sleepiness; used for narcolepsy evaluation. Assess medications contributing to sleep disruption: stimulants, corticosteroids, beta-agonists, diuretics, opioids, SSRIs.
Management of Obstructive Sleep Apnea
Continuous positive airway pressure (CPAP): first-line treatment; maintains airway patency with pneumatic splint. Autotitrating CPAP (APAP) adjusts pressure dynamically; improves comfort and adherence. Adherence is the major challenge; defined as 4 or more hours per night for 70% of nights. Desensitization programs, mask fitting, and humidification improve adherence.
Positional therapy: avoid supine sleeping in positional OSA; use wedge pillows or positional devices. Oral appliances: mandibular advancement devices for mild-moderate OSA or CPAP intolerance. Weight loss: 10% weight reduction can decrease AHI by 20-50% in overweight patients. Surgical options: uvulopalatopharyngoplasty (UPPP), hypoglossal nerve stimulation (Inspire device) for selected patients who fail CPAP.
Management of Insomnia
Cognitive Behavioral Therapy for Insomnia (CBT-I)
First-line treatment for chronic insomnia per American Academy of Sleep Medicine and American College of Physicians. Components: sleep restriction therapy, stimulus control, cognitive restructuring, sleep hygiene education, relaxation training. Sleep restriction: limit time in bed to match actual sleep time; consolidates sleep and increases sleep drive; gradually extend as efficiency improves. Stimulus control: bed is for sleep only; leave bed if unable to sleep within 20 minutes; maintain consistent wake time.
Effective in rehabilitation populations including TBI, SCI, and chronic pain; adapted formats available (telehealth, group, digital).
Pharmacological Options
Melatonin: 0.5-5 mg at bedtime; most useful for circadian rhythm disorders; limited evidence for primary insomnia. Melatonin receptor agonists (ramelteon 8 mg): targets MT1/MT2 receptors; no abuse potential. Orexin receptor antagonists (suvorexant, lemborexant): block wake-promoting orexin signaling; effective for sleep onset and maintenance; avoid in narcolepsy. Trazodone: 25-100 mg; commonly used off-label; sedating antihistamine and serotonergic effects; risk of orthostatic hypotension.
Z-drugs (zolpidem, eszopiclone): short-term use only; fall risk, complex sleep behaviors, cognitive impairment; avoid in elderly and TBI. Benzodiazepines: generally avoided in rehabilitation; impair neuroplasticity, increase fall risk, cause cognitive impairment, dependence potential. Gabapentin/pregabalin: useful when insomnia coexists with neuropathic pain or RLS.
Management of Circadian Rhythm Disorders
Light therapy: bright light exposure (10,000 lux) for 30 minutes in the morning to advance circadian phase; evidence in TBI and stroke. Melatonin: 0.5-3 mg administered 2-4 hours before desired sleep time for delayed phase; higher doses not more effective. Maintain consistent sleep-wake schedule including weekends. Minimize evening blue light exposure from screens. Structured daytime activity and social engagement reinforce circadian entrainment.
Management of Restless Legs Syndrome
Correct iron deficiency: supplement when ferritin less than 50 ng/mL (oral iron with vitamin C or IV iron for refractory cases). Dopamine agonists (pramipexole, ropinirole): effective but risk of augmentation with long-term use (earlier onset, increased intensity). Alpha-2-delta ligands (gabapentin, pregabalin): increasingly preferred as first-line to avoid augmentation. Review and discontinue medications that worsen RLS: SSRIs, antihistamines, antidopaminergic agents. Non-pharmacological: regular exercise, leg massage, warm baths, avoidance of caffeine and alcohol.
Environmental Optimization in Rehabilitation Settings
Minimize nighttime noise, light, and interruptions; cluster nursing care activities. Promote natural light exposure during the day and darkness at night. Establish consistent sleep-wake schedules within the rehabilitation program. Limit daytime napping to 20-30 minutes before 2 PM.
Address pain, toileting needs, and positioning for comfort before sleep. Temperature regulation: cool room temperature (65-68 degrees F) is optimal for sleep.
Key Clinical Pearls
OSA is present in the majority of stroke survivors but is dramatically underdiagnosed; screen all stroke patients with the STOP-BANG questionnaire and refer for sleep testing when positive. CBT-I is the first-line treatment for chronic insomnia, superior to medications in long-term outcomes; avoid benzodiazepines and Z-drugs in rehabilitation populations due to impaired neuroplasticity, fall risk, and cognitive side effects. Sleep disruption directly impairs neuroplasticity and motor learning; optimizing sleep is a rehabilitation intervention, not merely a comfort measure. In patients on chronic opioids, screen for central sleep apnea, which is dose-dependent and may require adaptive servo-ventilation rather than standard CPAP. Iron deficiency (ferritin less than 50 ng/mL) is a treatable cause of restless legs syndrome; always check ferritin before initiating pharmacotherapy.
References
- Mathias JL, Alvaro PK. Prevalence of sleep disturbances, disorders, and problems following traumatic brain injury: a meta-analysis. Sleep Medicine. 2012;13(7):898-905.
- Sankari A, Bascom AT, Badr MS. Upper airway mechanics in chronic spinal cord injury during sleep. Journal of Applied Physiology. 2014;116(12):1390-1395.
- Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine. 2016;165(2):125-133. 4. Wallace DM, Ramos AR, Rundek T. Sleep disorders and stroke. International Journal of Stroke. 2012;7(3):231-242.